HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liva L Krogh Selected Research

gastric inhibitory polypeptide (3-30)-amide

5/2021Effects of endogenous GIP in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liva L Krogh Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2021
1Overweight
01/2022
1Obesity
01/2022
1Bone Resorption
05/2021

Drug/Important Bio-Agent (IBA)

2gastric inhibitory polypeptide receptorIBA
01/2022 - 05/2021
1Glucagon-Like Peptide-1 ReceptorIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
05/2021
1gastric inhibitory polypeptide (3-30)-amideIBA
05/2021
1Peptides (Polypeptides)IBA
05/2021
1CollagenIBA
05/2021